Azactum 1 gm/5 ml (IM/IV Injection)

Title

• Azactum Injection

Categories

• Antibiotics
• Intramuscular and intravenous therapies
• Urinary tract infection treatment
• Respiratory tract infection treatment
• Septicemia treatment
• Skin and skin-structure infection treatment
• Intra-abdominal infection treatment
• Gynecologic infection treatment
• Adjunctive therapy

Description

• Azactum is indicated for the treatment of various infections caused by susceptible Gram-negative microorganisms such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, etc.
• It is a synthetic bactericidal monobactam antibiotic that inhibits bacterial cell wall synthesis by blocking peptidoglycan crosslinking
• Recommended dosages for adults and children for different types and severity of infections
• Administration routes including intramuscular, intravenous, and infusion
• Contraindications, side effects, pregnancy/lactation category, precautions & warnings, therapeutic class, and storage conditions

Color Options

• Clear solution for injection

Function

• Treatment of urinary tract infections
• Treatment of lower respiratory tract infections
• Treatment of septicemia
• Treatment of skin and skin-structure infections
• Treatment of intra-abdominal infections
• Treatment of gynecologic infections
• Adjunctive therapy to surgery

Material

• Aztreonam

Dosage for Adults

• 500 mg or 1 g every 8 or 12 hours for urinary tract infections
• 1 g or 2 g every 8 or 12 hours for moderately severe systemic infections
• 2 g every 6 or 8 hours for severe systemic or life-threatening infections

Dosage for Children

• 30 mg/kg every 6 hours for mild to moderate infections (over 1 week)
• 50 mg/kg every 6 or 8 hours for moderate to severe infections (2 years or older)

Maximum Recommended Dose

• 8 g per day for adults
• 120 mg/kg per day for pediatric patients

Administration Routes

• Intramuscular administration
• Intravenous administration
• Administration as an infusion

Interaction

• Clinically insignificant increases in serum levels when administered concomitantly with probenecid or furosemide

Contraindications

• Known hypersensitivity to Aztreonam or any other component in the formulation

Side Effects

• Local reactions like phlebitis/thrombophlebitis and discomfort/swelling at the injection site
• Systemic reactions like diarrhea, nausea, vomiting, and rash
• Other side effects including anaphylaxis, angioedema, bronchospasm, pancytopenia, neutropenia, etc.

Pregnancy Category

• Category B - use during pregnancy only if potential benefit justifies the potential risk
• Excreted in breast milk in concentrations less than 1% of maternal serum concentrations

Precautions & Warnings

• Appropriate monitoring recommended in patients with impaired hepatic or renal function

Therapeutic Class

• Other beta-lactam Antibiotics

Storage Conditions

• Store in a cool & dry place, protected from light & moisture

Dimensions

• N/A

Technical Specifications

• N/A

Design Elements

• Injection vial

Usability Features

• Intramuscular and intravenous use

Manufacturer

• N/A

Release Date

• N/A

Model Number

• N/A

Weight

• N/A

Volume

• N/A

Power Source

• N/A

Inclusions

• N/A

Accessories

• N/A

Warranty

• N/A

Certifications

• N/A

Country of Origin

• N/A

Additional Information

• N/A

Related Brands

• Azonam 1 gm/5 ml (IM/IV Injection) - incepta-pharmaceuticals-ltd